EQUIPHARMA
InactiveOverview
- Equity
- -€75,256
- Profit
- €82,111
SignalsneutralLatest accounts filed on timeShow the evidence
Signals
This company filed its last 7 accounts on average 63 days before the deadline; the Belgian median for financial year 2024 is 4 days before the deadline, and 38% of all filings were late.
Searched, nothing found (1)
- Resignations & appointments · End &…Resignation: VANDENEEDE Diederik (director) ·…
- Registered officeRegistered-office move
- Annual accounts filedfinancial year 2025 · micro…
Financials · financial year 2025, micro format
2021 to 2025, 5 financial years 2018 to 2025, 8 financial years
The operating result returns to profit in 2025: €83,239 after a loss of €260,942 in 2024, the highest result in the available series.
What the company sold each financial year and what was left of it. A loss stands below the zero line.
What the company owns (total assets), how much of it is its own (equity) and how much it owes.
Short-term assets minus short-term debts. Above zero the company can pay its bills in the short term.
Use the arrow keys on the chart for the figures per year.
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Non-recurring operating income76A | - | - | - | - | - | €10,895 | - | €181,884 | - |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €13,739 | €13,316 | €14,102 | €16,528 | €19,619 | €17,303 | €18,047 | - | - |
| Other operating charges640/8 | - | - | - | €2,549 | €2,441 | €2,707 | €2,742 | €1,902 | ▼ 30.6% |
| Non-recurring operating charges66A | - | - | - | - | €1,115 | €1,205 | €283,914 | - | - |
| Gross operating margin9900 | €37,631 | €59,934 | €59,469 | €46,303 | €43,207 | €57,672 | €43,760 | €85,141 | ▲ 94.6% |
| Operating profit (loss)9901 | €21,928 | €44,415 | €42,197 | €27,226 | €20,032 | €36,457 | -€260,942 | €83,239 | - |
| Financial income75/76B | - | - | - | - | - | - | €41 | - | - |
| Recurring financial income75 | - | €78 | €25 | - | - | - | €41 | - | - |
| Financial charges65/66B | - | - | - | €1,277 | €2,066 | €1,291 | €1,256 | €1,044 | ▼ 16.9% |
| Recurring financial charges65 | €1,987 | €1,711 | €1,374 | €1,277 | €2,066 | €1,291 | €1,256 | €1,044 | ▼ 16.9% |
| Profit (loss) for the period before taxes9903 | €19,940 | €42,782 | €40,848 | €25,949 | €17,966 | €35,166 | -€262,157 | €82,195 | - |
| Income taxes67/77 | €5,513 | €10,354 | €12,590 | €8,777 | €4,834 | €10,214 | €192 | €84 | ▼ 56.3% |
| Profit (loss) for the period9904 | €14,427 | €32,428 | €28,259 | €17,172 | €13,133 | €24,952 | -€262,349 | €82,111 | - |
| Profit (loss) for the period to be appropriated9905 | €14,427 | €32,428 | €28,259 | €17,172 | €13,133 | €24,952 | -€262,349 | €82,111 | - |
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Total assets20/58 | €206,685 | €199,485 | €178,604 | €152,980 | €170,243 | €165,385 | €166,609 | €14,973 | ▼ 91.0% |
| Fixed assets21/28 | €99,019 | €90,058 | €78,670 | €70,033 | €88,467 | €76,360 | €73,992 | - | - |
| Tangible fixed assets22/27 | €96,895 | €87,934 | €76,547 | €67,909 | €86,343 | €74,236 | €71,869 | - | - |
| Land and buildings22 | - | - | - | €59,968 | €82,203 | €67,882 | €53,562 | - | - |
| Plant, machinery and equipment23 | - | - | - | €3,390 | €3,535 | €4,242 | €17,875 | - | - |
| Furniture and vehicles24 | - | - | - | €4,550 | €605 | €2,112 | €433 | - | - |
| Financial fixed assets28 | €2,124 | €2,124 | €2,124 | €2,124 | €2,124 | €2,124 | €2,124 | - | - |
| Current assets29/58 | €107,666 | €109,427 | €99,933 | €82,947 | €81,776 | €89,025 | €92,617 | €14,973 | ▼ 83.8% |
| Stocks and contracts in progress3 | €44,277 | €45,900 | €42,197 | €54,386 | €53,845 | €55,767 | €51,841 | - | - |
| Stocks30/36 | - | - | - | €54,386 | €53,845 | €55,767 | €51,841 | - | - |
| Amounts receivable within one year40/41 | €59,044 | €57,992 | €30,689 | €27,198 | €26,759 | €31,093 | €38,976 | €5,078 | ▼ 87.0% |
| Trade receivables40 | - | - | - | €25,975 | €20,593 | €31,093 | €31,168 | €5,078 | ▼ 83.7% |
| Other amounts receivable41 | - | - | - | €1,223 | €6,166 | - | €7,808 | - | - |
| Cash at bank and in hand54/58 | €1,920 | €3,542 | €22,849 | - | - | - | €557 | €8,086 | ▲ 15× |
| Deferred charges and accrued income490/1 | - | - | - | €1,363 | €1,173 | €2,166 | €1,244 | €1,809 | ▲ 45.5% |
| Equity and liabilities | |||||||||
| Total equity and liabilities10/49 | €206,685 | €199,485 | €178,604 | €152,980 | €170,243 | €165,385 | €166,609 | €14,973 | ▼ 91.0% |
| Equity10/15 | €101,039 | €103,467 | €81,725 | €78,897 | €92,030 | €104,982 | -€157,367 | -€75,256 | ▲ 52.2% |
| Contributions10/11 | €6,200 | €6,200 | - | €6,200 | €6,200 | €6,200 | €6,200 | €6,200 | = |
| Reserves13 | €18,354 | €18,354 | €75,525 | €72,697 | €85,830 | €98,782 | €98,782 | €98,782 | = |
| Non-distributable reserves130/1 | - | - | - | €1,860 | €1,860 | - | - | - | - |
| Reserves not available under the articles1311 | - | - | - | €1,860 | €1,860 | - | - | - | - |
| Tax-exempt reserves132 | - | - | - | €16,494 | €16,494 | €16,494 | €16,494 | €16,494 | = |
| Distributable reserves133 | - | - | - | €54,344 | €67,476 | €82,289 | €82,289 | €82,289 | = |
| Profit (loss) carried forward14 | €76,485 | €78,913 | - | - | - | - | -€262,349 | -€180,238 | ▲ 31.3% |
| Amounts payable17/49 | €105,646 | €96,019 | €96,878 | €74,082 | €78,213 | €60,403 | €323,977 | €90,229 | ▼ 72.1% |
| Amounts payable after more than one year17 | €60,390 | €52,090 | €43,645 | €35,058 | €42,300 | €21,537 | €8,481 | - | - |
| Financial debts170/4 | - | - | - | €35,058 | €42,300 | €21,537 | €8,481 | - | - |
| Amounts payable within one year42/48 | €45,256 | €43,929 | €51,761 | €39,024 | €35,913 | €38,866 | €315,496 | €90,229 | ▼ 71.4% |
| Current portion of amounts payable after more than one year42 | - | - | - | €8,587 | €20,460 | €20,763 | €13,056 | - | - |
| Financial debts43 | - | - | - | €254 | €1,703 | €335 | - | - | - |
| Credit institutions430/8 | - | - | - | €254 | €1,703 | €335 | - | - | - |
| Trade debts44 | €22,639 | €14,633 | €17,255 | €18,312 | €11,954 | €10,446 | €301,576 | €3,992 | ▼ 98.7% |
| Suppliers440/4 | - | - | - | €18,312 | €11,954 | €10,446 | €301,576 | €3,992 | ▼ 98.7% |
| Taxes, remuneration and social security45 | - | - | - | €9,138 | €1,795 | €6,003 | €505 | €1,715 | ▲ 240% |
| Taxes450/3 | - | - | - | €9,138 | €1,795 | €6,003 | €505 | €1,715 | ▲ 240% |
| Other amounts payable47/48 | - | - | - | €2,733 | - | €1,319 | €359 | €84,522 | ▲ 236× |
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €14,427 | €32,428 | €28,259 | €17,172 | €13,133 | €24,952 | -€262,349 | €82,111 | - |
| + Depreciation and write-downs630 | €13,739 | €13,316 | €14,102 | €16,528 | €19,619 | €17,303 | €18,047 | - | - |
| Operating cash flow (approximation) | €28,166 | €45,744 | €42,361 | €33,700 | €32,752 | €42,255 | -€244,303 | €82,111 | - |
| Investment in fixed assets (approximation) | - | -€4,356 | -€2,714 | -€7,890 | -€38,053 | -€5,196 | -€15,679 | - | - |
| Change in cash | - | €1,622 | €19,307 | - | - | - | - | €7,529 | - |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Latest 10 of 24 filings with the National Bank
| Financial year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2025 | micro format | 19-03-2026 | 2026-00058370 |
| 31-12-2024 | micro format | 26-06-2025 | 2025-00189943 |
| 31-12-2023 | micro format | 20-06-2024 | 2024-00156292 |
| 31-12-2022 | micro format | 01-06-2023 | 2023-00104228 |
| 31-12-2021 | micro format | 02-06-2022 | 2022-20044771 |
| 31-12-2020 | micro format | 03-06-2021 | 2021-17200215 |
| 31-12-2019 | micro format | 04-06-2020 | 2020-14800067 |
| 31-12-2018 | micro format | 29-05-2019 | 2019-15100218 |
| 31-12-2017 | micro format | 31-05-2018 | 2018-15000594 |
| 31-12-2016 | micro format | 08-06-2017 | 2017-15900199 |
Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.
Directors
Mandate history
- Board
- began earlier
| Name | Functions and periods |
|---|---|
| VANDENEEDE Diederik |
|
Owners and capital
Capital and shareholders
- 22-06-2023 Converted to unavailable equity
Group and network
Connections & network
No directors read yet: 3 of 4 Gazette acts processed.
History
Acts, filings and financial milestones
13-08
Gazette deed
Resignations & appointments · End & cessationResignation: VANDENEEDE Diederik (director) · Net-asset statement · Auditor report20 facts ▸
- General meeting, 06-08-2026
- Other provision, “ontsluiting voorzitter voorlezing verslag bestuursorgaan, ontbinding” (deed in Dutch)
- Net-asset statement, 06-05-2026
- Other provision, “ontsluiting voorzitter voorlezing verslag bedrijfsrevisor, artikel 2:71 §2 WVV” (deed in Dutch)
- Auditor report, “Oudenaarde”, EUR (deed in Dutch)
- Other provision, “ontbinding en sluiting vereffening in één akte, artikel 2:80 WVV” (deed in Dutch)
- Other provision, “datum van ondertekening controleverslag” (deed in Dutch)
- Other provision, “vereffening deficitair, geen roerende voorheffing op liquidatiebonus” (deed in Dutch)
- Other provision, “akkoord aandeelhouder en bestuurder, ontbinding en sluiting vereffening in één akte” (deed in Dutch)
- Other provision, “laattijdige overhandiging stukken, geen wezenlijke invloed op controle” (deed in Dutch)
- Other provision, “kennisgeving aandeelhouder, kopie verslagen ontvangen, geen opmerkingen” (deed in Dutch)
- Dissolution, “ontbinding met dadelijke invereffeningstelling, artikel 2:80 WVV” (deed in Dutch)
- +8 further facts in this act
20-05
Gazette deed
Registered officeRegistered-office move2 facts ▸
- Board meeting, 28-11-2025
- Registered-office move, Willem van Vlasselaerstraat 13 te 3061 Leefdaal
22-06
Gazette deed
Resignation: Vandeneede Diederik (director)Reappointment: Vandeneede Diederik (director) · Amendment of the articles · Capital conversion10 facts ▸
- General meeting, “buitengewone algemene vergadering” (deed in Dutch)
- Amendment of the articles (2 times)
- Capital conversion, “statutair onbeschikbare eigen vermogensrekening” (deed in Dutch)
- Other provision, “vormen en meerderheden van statutenwijziging, beperking statutair onbeschikbare eigen vermogensrekening” (deed in Dutch)
- Capital
- Director resignation, Vandeneede Diederik (director)
- Director reappointment, Vandeneede Diederik (director (not named in the articles))
- Other provision, “kwijting ontslagnemende bestuurder voor uitoefening mandaat, algemene vergadering zal beslissen” (deed in Dutch)
- Registered office clause, “1800 Vilvoorde,Mechelsestraat 17” (deed in Dutch)
- Power of attorney, Notarisassociatie Lens. Abbeloos Notarissen
Show earlier events
About the unread acts
Of the 4 Belgian Official Gazette deeds we know for this company, 3 have been read. The other one has not been read yet: what they contain is neither established nor disproved here.
Inactive since August 2026
EQUIPHARMA has not been in the KBO register since 12 August 2026.
- Status
- Inactiveout of the register since 12 August 2026
- Last annual accounts
- financial year to 31 December 2025
- Last registered office
- Willem Van Vlasselaerstraat 13, 3061 Leefdaal (Bertem)as published on 13 August 2026
- Legal form
- Private limited company
- Active since
- 24 October 2001
Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.
Sites & property
1 parcel
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 24061D0018/00B002 | Flanders | 405 m² | 1 · 95 m² | 10.1 m · 2 |
How the parcels are linked
Articles of association
What the company does
- PurposeThe activities the company may carry out under its articles.
- “De aankoop en verkoop van farmaceutische producten van schoonheidsproducten en aanverwante producten; De aankoop en verkoop van…” (deed in Dutch)
7 activities (deed in Dutch)
- De aankoop en verkoop van farmaceutische producten van schoonheidsproducten en aanverwante producten
- De aankoop en verkoop van dieetproducten en orthopedische schoenen zowel bij groot- als kleinhandel
- De uitbating van apotheken
- De studie,de adviesverlening,expertise,engineering en elke dienstverlening in het kader van de hiervoor beschreven activiteiten
- Zij kan alle mogelijke commerciële,industriële,financiële,roerende en onroerende verrichtingen stellen die direct of indirect verband houden met haar voorwerp of die van die aard zijn dat ze de verwezenlijking en ontwikkeling ervan bevorderen
- Deelnemen in alle vennootschappen,verenigingen en ondernemingen zowel in België als in het buitenland,bij wijze van inbreng,inschrijving,overdracht,deelneming,fusie,financiële tussenkomst of anderszins
- En tevens de functies van bestuurder en vereffenaar uitoefenen in andere vennootschappen
- DurationHow long the company exists; usually unlimited, so until it is dissolved.
- Unlimited
- Name clauseThe name the company operates under according to its articles.
- EQUIPHARMA
- Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
- “Vlaams Gewest, administratieve zetels,agentschappen,werkhuizen,stapelplaatsen,bijkantoren” (deed in Dutch)
Who represents it, and how
- Who signsWho may bind the company towards others, for example by signing a contract.
- Each director alone
- Board ruleHow the board is made up, meets and takes decisions.
- “Met of zonder beperking van duur, 1” (deed in Dutch)“Alle handelingen nodig of nuttig voor verwezenlijking voorwerp, wet of statuten aan algemene vergadering voorbehouden” (deed in Dutch)
Meetings and financial year
- Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
- Third Saturday of June at 11:30
Oversight and winding up
- Dissolution ruleWhen and by whom the company can be dissolved.
- “Vormen vereist voor statutenwijziging, ontbinding op elk moment door beslissing algemene vergadering” (deed in Dutch)deed of 22-06-2023
- Liquidation ruleHow assets are shared after dissolution: creditors first, then shareholders.
- “Recht algemene vergadering om één of meerdere vereffenaars aan te duiden,bevoegdheden te omlijnen,vergoeding te bepalen, ontbinding om welke…” (deed in Dutch)deed of 22-06-2023
- Custody of recordsWhere the books and records are kept after liquidation, by law for at least five years.
- “Bij de wet verplichte termijn” (deed in Dutch)deed of 13-08-2026